Artificial Intelligence

Support for the American Cancer Society’s national Hope Lodge program enables a home away from home for patients and their caregivers. Philadelphia – December 5, 2019 – Proscia, a leading provider of AI-enabled digital pathology...

The Ibex Second Read™ System for breast is now deployed at Maccabi's pathology institute, making it the first lab in the world to implement AI-powered cancer diagnostics for breast biopsies in its routine clinical practice TEL AVIV,...

Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of €2.2 million in funding from the EU’s Horizon 2020 program. The EU grant was awarded to support Aiforia’s ongoing...

Aiforia announced the release of Velocity, the latest software release of tools, features and a new product, built upon the current scalable cloud platform, that allow medical and scientific experts to speed-up and simplify image analysis,...

REGISTER NOW Imagine an APP for nuclei segmentation that is reliable and can be used by anyone in your lab. Recent advances in deep learning and artificial intelligence have enabled Visiopharm to develop novel tools for nuclei...

The Danish-based leader in augmented pathology solutions Visiopharm has secured a grant worth £250,000 from UK Research and Innovation to test its innovative solutions in partnership with the NHS. The grant, offered by the UK Government’s...